AirFluSal Forspiro (fluticasone propionate salmeterol xinafoate): Reviews and patient testimonials
Back to the list of medications
Medication indications
AirFluSal Forspiro 50 microgram/500 microgram per actuation inhalation powder, pre-dispensed
AirFluSal Forspiro is indicated for use in adults 18 years of age and older only.
Asthma
AirFluSal Forspiro is indicated in the regular treatment of adults with severe asthma where use of a combination product (long-acting β2 agonist [LABA] and inhaled corticosteroid [ICS]) is appropriate:
Patients not adequately controlled on a lower strength corticosteroid combination product
or
Patients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist.
Chronic Obstructive Pulmonary Disease (COPD)
AirFluSal Forspiro is indicated for the symptomatic treatment of adults with COPD, with a forced expiratory volume in one second (FEV1) <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations and who have significant symptoms despite regular bronchodilator therapy.
Route of administration: opinion.traitement.inhalation
Molecule: fluticasone propionate, salmeterol xinafoate
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.